SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000921895-17-001933
Filing Date
2017-07-18
Accepted
2017-07-18 17:28:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 TO THE SCHEDULE 13G sc13ga907422cap_07182017.htm SC 13G/A 186345
  Complete submission text file 0000921895-17-001933.txt   188025
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Subject) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42745 | Film No.: 17970189
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice
Assistant Director 7